Pollens - grasses, fescue, meadow festuca elatior - Biologic Drug Details

Summary for pollens - grasses, fescue, meadow festuca elatior

Tradenames:	1
High Confidence Patents:	0
Applicants:	5
BLAs:	5
Suppliers: see list	4

Pharmacology for pollens - grasses, fescue, meadow festuca elatior

Physiological Effect	Cell-mediated Immunity Increased Histamine Release Increased IgG Production
Established Pharmacologic Class	Standardized Pollen Allergenic Extract
Chemical Structure	Allergens Pollen

Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

1. Brand-side disclosures in response to biosimilar applications

These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

2. General brand-side disclosures

These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

3. Patents from broad patent text search

For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for pollens - grasses, fescue, meadow festuca elatior Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for pollens - grasses, fescue, meadow festuca elatior Derived from Company Disclosures

No patents found based on company disclosures

3) Low Certainty: US Patents for pollens - grasses, fescue, meadow festuca elatior Derived from Patent Text Search

No patents found based on company disclosures

Pollens - grasses, fescue, meadow festuca elatior Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Biologic Drugs: Grass Pollen Allergies

Introduction to Grass Pollen Allergy Drugs

Grass pollen allergies are a common affliction affecting millions worldwide, leading to symptoms such as sneezing, itching, and watery eyes. The market for grass pollen allergy drugs is evolving, driven by advancements in healthcare technologies, rising awareness about allergies, and the growing demand for personalized medicine.

Market Growth and Forecast

The global grass pollen allergy drug market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 7.1% from 2024 to 2031. This growth is fueled by several key factors, including the increasing incidence of allergies, advancements in treatment options, and the rising awareness about preventive healthcare[1].

Key Market Trends

Personalized Medicine

Advancements in technology have enabled more personalized treatment options based on individual patient factors such as genetics and allergy severity. This tailored approach is expected to enhance patient outcomes and drive market growth[1].

Biologic Therapies

The development of biologic drugs offers new, targeted options for managing grass pollen allergies with potentially fewer side effects than traditional medications. Biologics are becoming increasingly popular due to their efficacy and safety profiles[1].

Market Consolidation

Mergers and acquisitions in the pharmaceutical industry are likely to lead to increased competition and innovation in the grass pollen allergy drug market. This consolidation can result in the development of new therapies and expanded product portfolios[1].

Product Types and Market Segmentation

The grass pollen allergy drug market is segmented into various product types, including:

BM-32 and Pollinex Quattro Grass

These are two commonly used drugs for treating grass pollen allergies. Pollinex Quattro Grass is particularly effective in desensitizing the immune system to allergens and holds a significant market share due to its efficacy[1].

Immunotherapy, Antihistamines, and Corticosteroids

Other types of drugs include immunotherapy, antihistamines, and corticosteroids. Immunotherapy, in particular, is gaining traction as it offers long-term relief by desensitizing patients to specific allergens.

Regional Market Analysis

The market for grass pollen allergy drugs is experiencing significant growth across various regions, including North America, Europe, Asia-Pacific, and the Middle East & Africa.

North America

This region is expected to be a lucrative market due to the high prevalence of allergies and the approval of novel medications. For instance, the FDA approval of new treatments like Ragwitek for ragweed pollen allergy has boosted the market[5].

Europe and Asia-Pacific

These regions are also witnessing substantial growth driven by increasing awareness about allergies and advancements in healthcare technologies. Key players are focusing on expanding their market presence through strategic partnerships and innovative marketing strategies[1].

Competitive Landscape

The competitive landscape of the grass pollen allergy drug market is characterized by several key players:

ALK-Abello A/S, Allergy Therapeutics Plc, Biomay AG

These companies are at the forefront of developing new therapies and expanding their product portfolios. They are investing heavily in research and development to cater to the rising demand for grass pollen allergy drugs[1].

Strategic Partnerships and Collaborations

Strategic partnerships between pharmaceutical companies and research institutions are expected to drive innovation and accelerate the entry of new products into the market. These collaborations are crucial for developing novel drug formulations with improved efficacy and safety profiles[1].

Innovative Growth Drivers

Novel Drug Formulations

The development of novel drug formulations with improved efficacy and safety profiles is a significant growth driver. These formulations often incorporate advanced technologies such as precision dosing and personalized medicine[1].

Digital Platforms and Telemedicine

Expanding market access through online pharmacies and telemedicine services is another innovative strategy. Leveraging digital platforms for targeted marketing and patient education can enhance patient adherence and satisfaction, ultimately driving market growth[1].

Economic and Environmental Impact

Economic Impact

The economic impact of grass pollen allergies is substantial, with significant costs associated with healthcare, lost productivity, and quality of life. Effective treatments can mitigate these costs and improve overall economic outcomes.

Environmental Impact

While not directly related to the drug market, the environmental impact of certain grass species like tall fescue (Festuca arundinacea) is noteworthy. Tall fescue can be invasive and reduce plant diversity in natural areas, highlighting the need for balanced agricultural practices[2].

Key Takeaways

• The global grass pollen allergy drug market is expected to grow at a CAGR of 7.1% from 2024 to 2031.
• Personalized medicine and biologic therapies are key trends driving market growth.
• Market segmentation includes BM-32, Pollinex Quattro Grass, immunotherapy, antihistamines, and corticosteroids.
• North America, Europe, and Asia-Pacific are significant regions for market growth.
• Strategic partnerships and digital platforms are crucial for innovation and market expansion.

FAQs

What is the expected CAGR for the global grass pollen allergy drug market from 2024 to 2031?

The global grass pollen allergy drug market is anticipated to grow at a CAGR of 7.1% from 2024 to 2031[1].

What are the key trends driving the growth of the grass pollen allergy drug market?

Key trends include the development of personalized medicine, biologic therapies, and market consolidation through mergers and acquisitions[1].

Which regions are expected to be lucrative for the grass pollen allergy drug market?

North America, Europe, and the Asia-Pacific region are expected to be significant markets due to high prevalence rates and advancements in healthcare technologies[1].

What role do biologic therapies play in the grass pollen allergy drug market?

Biologic therapies offer new, targeted options for managing grass pollen allergies with potentially fewer side effects than traditional medications, making them a growing segment of the market[1].

How are digital platforms impacting the grass pollen allergy drug market?

Digital platforms are enhancing market access through online pharmacies and telemedicine services, and they are also used for targeted marketing and patient education, which can improve patient adherence and satisfaction[1].

Sources

1. Global Grass Pollen Allergy Drug Market Trends: Insights into Growth Opportunities and Challenges forecasted from (2024 to 2031) - Reliableresearchtimes
2. Festuca elatior L. Tall fescue Kentucky fescue - Invasive.Org
3. What do you know about meadow fescue? - Ag Proud
4. Molecular resource for the forage grass meadow fescue (Festuca pratensis Huds.) - PubMed
5. Global Ragweed Pollen Allergy Treatment Market to be valued at US$ 1,147.3 Million by 2027, Says Coherent Market Insights (CMI) - Businesswire